• 摘要: 加速康复外科(ERAS)理念自1997年Kehlet教授提出后逐渐在外科各专业迅速普及和应用。其在食管外科领域亦显示出能减少术后并发症、缩短住院时间及改善患者预后等积极作用。中国医师协会胸外科分会快速康复专家委员会制订《食管癌加速康复外科技术应用专家共识(2016版)》,为ERAS技术在食管癌外科的临床规范应用起到了积极指导和规范作用。近年来,随着食管外科及相关领域ERAS理念的进步、微创技术与围手术期管理策略的快速发展,由国家癌症中心、中国医师协会胸外科医师分会、中华医学会胸心血管外科学分会、中国临床肿瘤学会食管癌专家委员会及国际食管疾病学会中国分会共同发起并组织多学科专家,采用德尔菲法制订《食管癌加速康复外科技术应用专家共识(2026版)》。共识系统阐述了食管癌ERAS路径在术前评估与优化、术中管理、术后康复及出院随访全周期的关键环节,形成4大类32项临床问题的推荐意见。共识基于最新循证医学证据,结合我国临床实践,旨在为我国食管癌ERAS技术的规范化实施提供指导,从而推动患者康复质量与远期生存获益的全面提升。

     

    Abstract: The concept of enhanced recovery after surgery (ERAS), proposed by professor Kehlet in 1997, has been widely adopted across various surgical specialties. In esophageal surgery, ERAS has demonstrated benefits including reduced postoperative complications, shorter hospital stays, and improved patient outcomes. In 2016, the Expert Committee on Rapid Recovery of the Chinese Association of Thoracic Surgeons (CATS) developed the Chinese expert consensus on enhanced recovery after esophagectomy (vision 2016), which has since played an important role in guiding and standardizing its clinical application. Over the recent years, considerable progress has been made in the ERAS concept, minimally invasive esophagectomy techniques, and related fields. To adapt to these advances, the National Cancer Center, the Chinese Society of Thoracic and Cardiovascular Surgery, the Esophageal Cancer Expert Committee of Chinese Society of Clinical Oncology, and the Chinese Society for Diseases of the Esophagus, convened esophageal surgery specialists and multidis-ciplinary experts from related fields, to update the 2016 consensus using the Delphi method, and develop Expert consensus on the application of enhanced recovery after surgery in esophageal cancer (2026 edition). This consensus systematically outlines the key components of the ERAS pathway for esophageal cancer across the full cycle of care, including preoperative assessment and optimization, intraoperative management, postoperative rehabilitation, and post-discharge follow‑up. In total, it provides 32 recommendations spanning four major categories of clinical issues. Grounded in the latest evidence, tailored to Chinese clinical practice, this document aims to guide the standardized implementation of ERAS in esophageal cancer, thereby enhancing patients′ quality of recovery and long‑term survival.

     

/

返回文章
返回